Physician profile
Dharmendra V Patel
NPI 1942262571
$36,322.39
in general payments reported to CMS, 2019-2025
44 companies · $5,376 in 2025
The $5,376 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,867 · 2021: $2,223 · 2022: $2,785 · 2023: $1,865 · 2024: $7,035 · 2025: $5,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,494 · Travel and Lodging: $4,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,493.82 |
| Travel and Lodging | $4,781.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,098.98 | 2019-2020 | |
| Medtronic, INC. | $9,739.87 | 2021-2025 | Onyx Frontier, Symplicity G3, Intellis Adaptivestim |
| Pfizer INC. | $6,097.65 | 2019-2025 | |
| Abbott Laboratories | $3,493.90 | 2019-2025 | Aveir, Assurity, Ensite Precision |
| Novartis Pharmaceuticals Corporation | $1,079.69 | 2019-2025 | |
| Shockwave Medical, INC | $1,028.69 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $550.16 | 2019-2024 | Repatha |
| Novo Nordisk INC | $514.89 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $464.85 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $458.94 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $394.75 | 2020-2025 | Wainua, Farxiga |
| Penumbra, INC. | $291.73 | 2024 | Indigo System |
| Cardiovascular Systems INC. | $237.71 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $236.58 | 2021-2024 | Camzyos |
| Merck Sharp & Dohme LLC | $188.50 | 2021-2024 | Verquvo |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $148.06 | 2023 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $136.72 | 2022 | |
| Biosense Webster, INC. | $120.59 | 2024-2025 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $115.80 | 2022-2025 | Onpattro, Amvuttra |
| Boston Scientific Corporation | $110.70 | 2022-2025 | Emerge Push, General - Brady |
| Sanofi-Aventis U.S. LLC | $102.86 | 2019-2022 | |
| Cordis US Corp. | $93.72 | 2023-2025 | Vista Brite Tip, Mynx Control, Brite Tip Radianz |
| Glaxosmithkline, LLC. | $91.24 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.93 | 2022-2025 | Lifevest |
| Biotronik INC. | $64.92 | 2022 | |
| Inspire Medical Systems, INC. | $62.46 | 2023-2024 | Inspire |
| Lexicon Pharmaceuticals, INC. | $53.84 | 2023-2024 | Inpefa |
| Avinger INC. | $45.81 | 2022 | |
| Daiichi Sankyo INC. | $37.80 | 2024 | Injectafer |
| Angiodynamics, INC. | $27.28 | 2022 | |
| Cvrx, INC. | $24.84 | 2023 | Barostim Neo System |
| Abiomed | $23.59 | 2019 | |
| Terumo Medical Corporation | $17.04 | 2021 | |
| Cardiva Medical, INC. | $16.63 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cook Medical LLC | $14.23 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.66 | 2019 | |
| Atricure, INC. | $13.65 | 2022 | |
| Amarin Pharma, INC. | $12.20 | 2021 | |
| Lundbeck LLC | $12.14 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $9.96 | 2025 | Rhythm Express |
| Elutia, INC. | $9.83 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharmendra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.